Avalo Therapeutics (AVTX) Other Gross PP&E Adjustments (2014 - 2026)
Avalo Therapeutics posted quarterly Other Gross PP&E Adjustments of -$268000.0 for Q1 2026, up 56.42% year-on-year from -$171330.6 in Q1 2025, and down 168.0% on a QoQ basis from -$100000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Other Gross PP&E Adjustments data on file, last reported at -$268000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 56.42% year-over-year to -$268000.0; the trailing twelve-month figure through Mar 2026 stood at -$268000.0 (up 56.42% YoY), and the FY2025 full-year result was -$100000.0, down 113.85% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$268000.0, down from -$100000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $722000.0 in Q4 2024 and bottomed at -$1.9 million in Q1 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$1.1 million (2024), against an average of -$802470.6.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments sank 159.74%; it then surged 64.71% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $582000.0 in 2022, then gained by 23.37% to $718000.0 in 2023, then advanced by 0.56% to $722000.0 in 2024, then slumped by 113.85% to -$100000.0 in 2025, then tumbled by 168.0% to -$268000.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$268000.0 (Q1 2026), -$100000.0 (Q4 2025), and -$402000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | -268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | -402,000.00 |
| Sep 30, 2025 | -402,000.00 |
| Jun 30, 2025 | -487,000.00 |
| Jun 30, 2025 | -487,000.00 |
| Mar 31, 2025 | -615,000.00 |
| Mar 31, 2025 | -615,000.00 |
| Dec 31, 2024 | 722,000.00 |
| Dec 31, 2024 | 722,000.00 |
| Sep 30, 2024 | -1.14 Mn |
| Sep 30, 2024 | -1.14 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | 718,000.00 |
| Dec 31, 2023 | 718,000.00 |
| Sep 30, 2023 | -1.39 Mn |
| Sep 30, 2023 | -1.39 Mn |
| Jun 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -1.46 Mn |
| Mar 31, 2023 | -1.68 Mn |
| Mar 31, 2023 | -1.68 Mn |
| Dec 31, 2022 | 582,000.00 |
| Dec 31, 2022 | 582,000.00 |
| Sep 30, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.81 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Mar 31, 2022 | -1.94 Mn |
| Mar 31, 2022 | -1.94 Mn |
| Dec 31, 2021 | 587,000.00 |
| Dec 31, 2021 | 587,000.00 |
| Sep 30, 2021 | -698,000.00 |
| Sep 30, 2021 | -698,000.00 |
| Jun 30, 2021 | -773,000.00 |
| Jun 30, 2021 | -773,000.00 |
| Mar 31, 2021 | -846,000.00 |
| Mar 31, 2021 | -846,000.00 |
| Dec 31, 2020 | 521,000.00 |
| Dec 31, 2020 | 521,000.00 |
| Sep 30, 2020 | -983,411.00 |
| Sep 30, 2020 | -983,411.00 |
| Jun 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | -1.06 Mn |
| Mar 31, 2020 | -710,230.00 |
| Mar 31, 2020 | -710,230.00 |
| Dec 31, 2019 | 646,439.00 |
| Dec 31, 2019 | 646,439.00 |
| Sep 30, 2019 | -719,113.00 |
| Sep 30, 2019 | -719,113.00 |
| Jun 30, 2019 | -728,138.00 |
| Jun 30, 2019 | -728,138.00 |
| Mar 31, 2019 | -737,658.00 |
| Mar 31, 2019 | -737,658.00 |
| Dec 31, 2018 | 718,675.00 |
| Dec 31, 2018 | 718,675.00 |
| Dec 31, 2017 | -4,457.00 |
| Dec 31, 2017 | -4,457.00 |
| Dec 31, 2016 | -23,911.00 |
| Dec 31, 2016 | -23,911.00 |
| Dec 31, 2015 | 96,051.00 |
| Dec 31, 2015 | 96,051.00 |
| Dec 31, 2014 | 76,068.00 |
| Dec 31, 2014 | 76,068.00 |